SIRT1/AMPK signaling is an energy-sensitive pathway that regulates various physiological reactions, including catabolic metabolism, angiogenesis, cell survival, and insulin resistance [40,41], and can antagonize the pathogenesis of NAFLD [42,43,44]. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.